Needham upgrades Rocket Pharmaceuticals to Buy, sets $9 target
Needham upgraded Rocket Pharmaceuticals to Buy and set a $9.00 price target, implying 163.9% upside versus the Sep 15 close of $3.41.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.